ICCC
Price
$6.66
Change
+$0.13 (+1.99%)
Updated
Sep 4, 01:48 PM (EDT)
Capitalization
59.03M
74 days until earnings call
JANX
Price
$23.29
Change
+$0.25 (+1.09%)
Updated
Sep 4, 02:16 PM (EDT)
Capitalization
1.38B
68 days until earnings call
Interact to see
Advertisement

ICCC vs JANX

Header iconICCC vs JANX Comparison
Open Charts ICCC vs JANXBanner chart's image
ImmuCell
Price$6.66
Change+$0.13 (+1.99%)
Volume$100
Capitalization59.03M
Janux Therapeutics
Price$23.29
Change+$0.25 (+1.09%)
Volume$200
Capitalization1.38B
ICCC vs JANX Comparison Chart in %
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. JANX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Buy and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ICCC: $6.53 vs. JANX: $23.04)
Brand notoriety: ICCC and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 33% vs. JANX: 61%
Market capitalization -- ICCC: $59.03M vs. JANX: $1.38B
ICCC [@Biotechnology] is valued at $59.03M. JANX’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, ICCC is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 6 TA indicator(s) are bullish while JANX’s TA Score has 2 bullish TA indicator(s).

  • ICCC’s TA Score: 6 bullish, 3 bearish.
  • JANX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ICCC is a better buy in the short-term than JANX.

Price Growth

ICCC (@Biotechnology) experienced а +6.98% price change this week, while JANX (@Biotechnology) price change was -1.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.71%. For the same industry, the average monthly price growth was +5.90%, and the average quarterly price growth was +27.78%.

Reported Earning Dates

ICCC is expected to report earnings on Nov 17, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.39B) has a higher market cap than ICCC($59M). ICCC YTD gains are higher at: 26.718 vs. JANX (-56.967). ICCC has higher annual earnings (EBITDA): 4.96M vs. JANX (-142.8M). JANX has more cash in the bank: 996M vs. ICCC (6M). ICCC has less debt than JANX: ICCC (14.3M) vs JANX (22.2M). ICCC has higher revenues than JANX: ICCC (28.3M) vs JANX (439K).
ICCCJANXICCC / JANX
Capitalization59M1.39B4%
EBITDA4.96M-142.8M-3%
Gain YTD26.718-56.967-47%
P/E Ratio31.08N/A-
Revenue28.3M439K6,446%
Total Cash6M996M1%
Total Debt14.3M22.2M64%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
79
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCJANX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 23 days ago
77%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UEPEP72.360.11
+0.15%
Union Electric Co.
STLY3.90N/A
N/A
HG Holdings, Inc.
ALEGF7.65N/A
N/A
ALLEGRO EU SA
HTSUY6.80N/A
N/A
Hisamitsu Pharmaceutical Co., Ltd.
CCARF1.01-0.05
-4.72%
Colonial Coal International Corp

ICCC and

Correlation & Price change

A.I.dvisor tells us that ICCC and UNCY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICCC and UNCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
+5.60%
UNCY - ICCC
29%
Poorly correlated
-0.69%
CDTX - ICCC
24%
Poorly correlated
-0.56%
MYNDF - ICCC
24%
Poorly correlated
N/A
TRAW - ICCC
23%
Poorly correlated
+11.81%
JANX - ICCC
23%
Poorly correlated
+0.79%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SNTI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+0.79%
SNTI - JANX
43%
Loosely correlated
+1.05%
CYCN - JANX
41%
Loosely correlated
-3.39%
TERN - JANX
36%
Loosely correlated
-1.59%
PPBT - JANX
36%
Loosely correlated
N/A
BNTX - JANX
36%
Loosely correlated
-0.20%
More